Anifrolumab Malignancy and Serious Infections Study
Anifrolumab Malignancy and Serious Infections Study
Recruiting · NCT07000110 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anifrolumab Malignancy and Serious Infections Study | Infections, Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, neoplasm, systemic lupus erythematosus | Recruiting | Not stated | 2026-09-16 | NCT07000110 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| IQVIA Pty Ltd | 25 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||